Chaozhi Tang
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Integrated Genomic and Single-Cell Analysis Reveals Heterogeneity, Prognosis, and Treatment Vulnerability in Urothelial Carcinoma.
Journal: Human mutation
Published: February 07, 2026
PARP1-BCAT2 axis upregulates ABCG1 via histone lactylation to drive acquired PARP inhibitor resistance in prostate cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 08, 2026
Liquid biopsy based on multi-targeted capture of urinary tumor DNA combined with machine learning to detect urothelial carcinoma: a multicenter prospective study.
Journal: International urology and nephrology
Published: August 27, 2025
BCAT2 binding to PCBP1 regulates the PI3K/AKT signaling pathway to inhibit autophagy-related apoptosis and ferroptosis in prostate cancer.
Journal: Cell death & disease
Published: November 30, 2024
Correction: ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer.
Journal: Experimental hematology & oncology
Published: May 20, 2024
ScRNA-seq revealed the tumor microenvironment heterogeneity related to the occurrence and metastasis in upper urinary tract urothelial carcinoma.
Journal: Cancer gene therapy
Published: December 13, 2023
ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer.
Journal: Experimental hematology & oncology
Published: December 02, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026